Literature DB >> 23490481

Growth control and ribosomopathies.

Teng Teng1, George Thomas, Carol A Mercer.   

Abstract

Ribosome biogenesis and protein synthesis are two of the most energy consuming processes in a growing cell. Moreover, defects in their molecular components can alter the pattern of gene expression. Thus it is understandable that cells have developed a surveillance system to monitor the status of the translational machinery. Recent discoveries of causative mutations and deletions in genes linked to ribosome biogenesis have defined a group of similar pathologies termed ribosomopathies. Over the past decade, much has been learned regarding the relationship between growth control and ribosome biogenesis. The discovery of extra-ribosomal functions of several ribosome proteins and their regulation of p53 levels has provided a link from ribosome impairment to cell cycle regulation. Yet, evidence suggesting p53 and/or Hdm2 independent pathways also exists. In this review, we summarize recent advances in understanding the mechanisms underlying the pathologies of ribosomopathies and discuss the relationship between ribosome production and tumorigenesis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23490481     DOI: 10.1016/j.gde.2013.02.001

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  52 in total

Review 1.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

2.  Emergence of hematopoietic stem and progenitor cells involves a Chd1-dependent increase in total nascent transcription.

Authors:  Fong Ming Koh; Carlos O Lizama; Priscilla Wong; John S Hawkins; Ann C Zovein; Miguel Ramalho-Santos
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 3.  Translational Control during Cellular Senescence.

Authors:  Matthew J Payea; Carlos Anerillas; Ravi Tharakan; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

Review 4.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

5.  Haploinsufficiency screen highlights two distinct groups of ribosomal protein genes essential for embryonic stem cell fate.

Authors:  Simon Fortier; Tara MacRae; Mélanie Bilodeau; Tobias Sargeant; Guy Sauvageau
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

6.  RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors.

Authors:  Queenie Wing-Lei Wong; Jia Li; Sheng Rong Ng; Seng Gee Lim; Henry Yang; Leah A Vardy
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

7.  Chd1 is essential for the high transcriptional output and rapid growth of the mouse epiblast.

Authors:  Marcela Guzman-Ayala; Michael Sachs; Fong Ming Koh; Courtney Onodera; Aydan Bulut-Karslioglu; Chih-Jen Lin; Priscilla Wong; Rachel Nitta; Jun S Song; Miguel Ramalho-Santos
Journal:  Development       Date:  2014-12-05       Impact factor: 6.868

8.  Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies.

Authors:  Catherine E Scull; Yinfeng Zhang; Nichole Tower; Lynn Rasmussen; Indira Padmalayam; Robert Hunter; Ling Zhai; Robert Bostwick; David A Schneider
Journal:  Biochem J       Date:  2019-08-09       Impact factor: 3.857

9.  Arabidopsis small nucleolar RNA monitors the efficient pre-rRNA processing during ribosome biogenesis.

Authors:  Pan Zhu; Yuqiu Wang; Nanxun Qin; Feng Wang; Jia Wang; Xing Wang Deng; Danmeng Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-05       Impact factor: 11.205

10.  High-throughput transcriptome sequencing identifies candidate genetic modifiers of vulnerability to fetal alcohol spectrum disorders.

Authors:  Ana Garic; Mark E Berres; Susan M Smith
Journal:  Alcohol Clin Exp Res       Date:  2014-06-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.